These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 9711937
1. Vessel dilator enhances sodium and water excretion and has beneficial hemodynamic effects in persons with congestive heart failure. Vesely DL, Dietz JR, Parks JR, Baig M, McCormick MT, Cintron G, Schocken DD. Circulation; 1998 Jul 28; 98(4):323-9. PubMed ID: 9711937 [Abstract] [Full Text] [Related]
2. Comparison of vessel dilator and long-acting natriuretic peptide in the treatment of congestive heart failure. Vesely DL, Dietz JR, Parks JR, Antwi EA, Overton RM, McCormick MT, Cintron G, Schocken DD. Am Heart J; 1999 Oct 28; 138(4 Pt 1):625-32. PubMed ID: 10502206 [Abstract] [Full Text] [Related]
3. Combined treatment with vessel dilator and kaliuretic hormone in persons with congestive heart failure. Patel H, Dietz JR, Owen A, San Miguel G, McCormick MT, Schocken DD, Vesely DL. Exp Biol Med (Maywood); 2004 Jun 28; 229(6):521-7. PubMed ID: 15169971 [Abstract] [Full Text] [Related]
4. Effects of kaliuretic peptide on sodium and water excretion in persons with congestive heart failure. Nasser A, Dietz JR, Siddique M, Patel H, Khan N, Antwi EK, San Miguel GI, McCormick MT, Schocken DD, Vesely DL. Am J Cardiol; 2001 Jul 01; 88(1):23-9. PubMed ID: 11423053 [Abstract] [Full Text] [Related]
6. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer? Vesely DL. Clin Exp Pharmacol Physiol; 2006 Mar 01; 33(3):169-76. PubMed ID: 16487258 [Abstract] [Full Text] [Related]
7. Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance urinary excretion rate of albumin, total protein, and beta(2)-microglobulin in patients with congestive heart failure. Vesely DL, Perez-Lamboy GI, Schocken DD. J Card Fail; 2001 Mar 01; 7(1):55-63. PubMed ID: 11264551 [Abstract] [Full Text] [Related]
8. Atrial natriuretic peptides in the diagnosis and treatment of congestive heart failure. Vesely DL. Congest Heart Fail; 1999 Mar 01; 5(4):171-179. PubMed ID: 12189309 [Abstract] [Full Text] [Related]
9. Intact negative feedback of four cardiac hormones in congestive heart failure. Vesely DL, San Miguel GI, Hassan I, Schocken DD. Metabolism; 2002 May 01; 51(5):582-8. PubMed ID: 11979389 [Abstract] [Full Text] [Related]
10. Atrial natriuretic hormones originating from the N-terminus of the atrial natriuretic factor prohormone. Vesely DL. Clin Exp Pharmacol Physiol; 1995 Feb 01; 22(2):108-14. PubMed ID: 7621602 [Abstract] [Full Text] [Related]
11. Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans. Vesely DL, Douglass MA, Dietz JR, Gower WR, McCormick MT, Rodriguez-Paz G, Schocken DD. Circulation; 1994 Sep 01; 90(3):1129-40. PubMed ID: 8087923 [Abstract] [Full Text] [Related]
12. Cardiorenal effects of atrial natriuretic factor administration in congestive heart failure: natriuresis and diuresis without hemodynamic alterations. Firth BG, Perna R, Bellomo JF, Toto RD. Am J Med Sci; 1989 Apr 01; 297(4):203-8. PubMed ID: 2565086 [Abstract] [Full Text] [Related]
13. Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance the urinary excretion rate of beta2-microglobulin. Vesely DL, Perez-Lamboy GI, Schocken DD. Metabolism; 2000 Dec 01; 49(12):1592-7. PubMed ID: 11145122 [Abstract] [Full Text] [Related]
14. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Saito Y, Nakao K, Nishimura K, Sugawara A, Okumura K, Obata K, Sonoda R, Ban T, Yasue H, Imura H. Circulation; 1987 Jul 01; 76(1):115-24. PubMed ID: 2954723 [Abstract] [Full Text] [Related]
15. Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure. Fifer MA, Molina CR, Quiroz AC, Giles TD, Herrmann HC, De Scheerder IR, Clement DL, Kubo S, Cody RJ, Cohn JN. Am J Cardiol; 1990 Jan 15; 65(3):211-6. PubMed ID: 2136969 [Abstract] [Full Text] [Related]
16. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure. Mitrovic V, Seferovic P, Dodic S, Krotin M, Neskovic A, Dickstein K, de Voogd H, Böcker C, Ziegler D, Godes M, Nakov R, Essers H, Verboom C, Hocher B. Circ Heart Fail; 2009 Nov 15; 2(6):523-31. PubMed ID: 19919976 [Abstract] [Full Text] [Related]
17. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Yoshimura M, Yasue H, Morita E, Sakaino N, Jougasaki M, Kurose M, Mukoyama M, Saito Y, Nakao K, Imura H. Circulation; 1991 Oct 15; 84(4):1581-8. PubMed ID: 1914098 [Abstract] [Full Text] [Related]
18. Efficacy of prolonged infusion of urodilatin [ANP-(95-126)] in patients with congestive heart failure. Elsner D, Muders F, Müntze A, Kromer EP, Forssmann WG, Riegger GA. Am Heart J; 1995 Apr 15; 129(4):766-73. PubMed ID: 7900630 [Abstract] [Full Text] [Related]
19. Effects of clonidine on renal sympathetic nerve activity, natriuresis and diuresis in chronic congestive heart failure rats. Feng QP, Carlsson S, Thorén P, Hedner T. J Pharmacol Exp Ther; 1992 Jun 15; 261(3):1129-35. PubMed ID: 1534840 [Abstract] [Full Text] [Related]
20. Vessel dilator, long acting natriuretic peptide, and kaliuretic peptide increase circulating prostaglandin E2. Vesely DL, Perez-Lamboy GI, Schocken DD. Life Sci; 2000 Jun 15; 66(10):905-13. PubMed ID: 10714891 [Abstract] [Full Text] [Related] Page: [Next] [New Search]